CN113679051A - Peony polypeptide powder, solid beverage and application thereof - Google Patents
Peony polypeptide powder, solid beverage and application thereof Download PDFInfo
- Publication number
- CN113679051A CN113679051A CN202110973779.5A CN202110973779A CN113679051A CN 113679051 A CN113679051 A CN 113679051A CN 202110973779 A CN202110973779 A CN 202110973779A CN 113679051 A CN113679051 A CN 113679051A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- peony
- peony polypeptide
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 154
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 63
- 235000006484 Paeonia officinalis Nutrition 0.000 title claims abstract description 60
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 47
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 45
- 235000013361 beverage Nutrition 0.000 title claims abstract description 7
- 239000007787 solid Substances 0.000 title claims abstract description 7
- 244000170916 Paeonia officinalis Species 0.000 title 1
- 241000736199 Paeonia Species 0.000 claims abstract description 59
- 239000002994 raw material Substances 0.000 claims abstract description 37
- 240000008042 Zea mays Species 0.000 claims abstract description 25
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 25
- 235000005822 corn Nutrition 0.000 claims abstract description 25
- 235000020197 coconut milk Nutrition 0.000 claims abstract description 21
- 229940067866 dandelion extract Drugs 0.000 claims abstract description 19
- 235000020691 dandelion extract Nutrition 0.000 claims abstract description 19
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims abstract description 19
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 18
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 17
- 244000269722 Thea sinensis Species 0.000 claims abstract description 17
- 235000009569 green tea Nutrition 0.000 claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 210000004185 liver Anatomy 0.000 claims abstract description 15
- 239000003094 microcapsule Substances 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 241000220317 Rosa Species 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 12
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 12
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 12
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 10
- 230000036772 blood pressure Effects 0.000 claims abstract description 9
- 210000003734 kidney Anatomy 0.000 claims abstract description 9
- 102000015636 Oligopeptides Human genes 0.000 claims description 18
- 108010038807 Oligopeptides Proteins 0.000 claims description 18
- 241000208340 Araliaceae Species 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 241000251468 Actinopterygii Species 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 241000361919 Metaphire sieboldi Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 17
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 17
- 229940116269 uric acid Drugs 0.000 abstract description 17
- 230000004060 metabolic process Effects 0.000 abstract description 13
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 6
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 210000000941 bile Anatomy 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 241000190633 Cordyceps Species 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 5
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 229940089161 ginsenoside Drugs 0.000 description 4
- 229930182494 ginsenoside Natural products 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000002547 Rosa roxburghii Species 0.000 description 3
- 235000000640 Rosa roxburghii Nutrition 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241001480006 Clavicipitaceae Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004404 adrenal cortex Anatomy 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000007686 potassium Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000186367 Mycobacterium avium Species 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001231 Polysaccharide peptide Polymers 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000028938 Urination disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 108010070324 lumbrokinase Proteins 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 108010022457 polysaccharide peptide Proteins 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229940070017 potassium supplement Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to peony polypeptide powder, a solid beverage and application thereof, wherein the peony polypeptide powder comprises the following raw material components: 15-30 parts of coconut milk powder, 10-25 parts of dandelion extract, 10-25 parts of maltodextrin, 10-25 parts of corn stigma extract, 5-10 parts of peony seed oil microcapsule powder, 5-15 parts of green tea powder, 5-15 parts of poria cocos powder, 5-15 parts of coix seed, 5-15 parts of roxburgh rose powder, 0.1-2 parts of cordyceps militaris, 0.1-2 parts of tuna peptide powder and 0.1-2 parts of ginseng powder. The peony polypeptide powder has the effects of promoting uric acid metabolism, resolving dampness, removing food stagnation, assisting in reducing blood sugar and blood pressure, nourishing and protecting liver, and tonifying spleen and kidney.
Description
Technical Field
The invention belongs to the technical field of food, and particularly relates to peony polypeptide powder, a solid beverage of the peony polypeptide powder and application of the peony polypeptide powder.
Background
Along with the continuous improvement of the living standard of modern people, the working pressure is higher and higher, the accumulation of bad living habits and the like, hypertension, hyperglycemia, hyperlipidemia and hyperuricemia are accompanied in more and more people, and become high-risk factors of cardiovascular and cerebrovascular diseases, thereby causing great troubles to the life of people. If the four high points are not well and effectively controlled, coronary heart disease, angina pectoris, myocardial infarction, cerebral apoplexy (ischemic stroke or hemorrhagic stroke) and the like are easily caused, so daily health care is particularly important.
Disclosure of Invention
The invention aims to provide peony polypeptide powder, a solid beverage thereof and application thereof, wherein the peony polypeptide powder can promote uric acid metabolism, assist in reducing blood sugar, blood pressure and blood fat, help a human body to control blood sugar, blood fat, blood pressure and uric acid within a normal range, avoid complications and improve life quality. Besides, the invention also has the functions of eliminating dampness, removing food stagnation, nourishing and protecting liver, tonifying spleen and kidney and the like.
In order to achieve the purpose, the invention adopts the following technical scheme:
the peony polypeptide powder comprises the following raw material components in parts by weight:
15-30 parts of coconut milk powder, 10-25 parts of dandelion extract, 10-25 parts of maltodextrin, 10-25 parts of corn stigma extract, 5-10 parts of peony seed oil microcapsule powder, 5-15 parts of green tea powder, 5-15 parts of poria cocos powder, 5-15 parts of coix seed, 5-15 parts of roxburgh rose powder, 0.1-2 parts of cordyceps militaris, 0.1-2 parts of tuna peptide powder and 0.1-2 parts of ginseng powder.
The coconut milk powder is made up by using coconut milk squeezed from fresh coconut through the processes of spray drying and drying. The coconut milk powder contains protein, fat, carbohydrate, dietary fiber, vitamins A, B1, B2 and C, E, and also contains nutrient elements such as iron, zinc, calcium, magnesium, phosphorus and the like. The coconut milk powder has high protein content, so that the coconut milk powder becomes an instant drink with the highest amino acid content in the world, and the amino acid has great effects on the growth and development of children, the metabolism of ordinary people, the aging resistance and the disease prevention of the old people and the production of body energy for daily activities. The coconut milk powder can improve the nutrient intake of human body, thereby enhancing the body immunity. The coconut milk powder is rich in B vitamins, can relieve neuritis, inflammation of mouth and horn, cardiovascular disease and beriberi, and has auxiliary effect on pregnant women (lack of B1 during pregnancy) and diabetic (lack of B2 easily).
The dandelion extract has the effects of clearing heat and removing toxicity, reducing swelling and resolving masses, inducing diuresis and treating stranguria and the like, and the pharmacological effects of the dandelion extract comprise the following steps according to modern pharmacological research: 1. improving liver function: dandelion extract is applied to liver inflammation and congestion, and is one of the most effective antidotal herbs, and plays a role in filtering toxins and waste products in blood flow, gall bladder, liver and kidney. It stimulates bile secretion and helps the body to remove excess water made by the damaged liver. 2. Promoting bile secretion: the flavonoids from dandelion extract double the bile flow, which is very critical in the elimination of toxins, since bile flow is essentially the natural secretory process that transports toxins from the liver to the intestine, where they are excreted. In addition, the dandelion extract can restore the bile function besides accelerating bile flow. Its choleretic action is beneficial for inflammation of the liver and gallbladder, removal of gallstones and congestion, and jaundice. 3. And (3) diuresis: the dandelion leaf extract is a potent diuretic. Unlike many traditional diuretics, dandelion leaves do not leach out the potassium element in the body. In fact, the dandelion leaves contain a lot of these minerals and can even function as a potassium supplement, and this diuretic effect is reliable in the use of dandelion for the treatment of hypertension.
The corn stigma extract has the effects of promoting diuresis and reducing edema, and clearing liver and benefiting gallbladder. Modern pharmacological research finds that the traditional Chinese medicine composition has the effects of reducing blood fat, preventing cancer, resisting bacteria, enhancing immunity, facilitating urination, reducing blood pressure and the like. The corn stigma extract can improve the metabolism of the glycolipid of the type 2 diabetes cell model and relieve the harm of toxic and side effects of the glycolipid of the type 2 diabetes on the functions of pancreas, heart, liver and kidney, thereby slowing down the development trend of disease symptoms.
The peony seed oil microcapsule powder mainly comprises peony seed oil, wherein the content of unsaturated fatty acid in the peony seed oil is more than 90%, and the content of polyunsaturated fatty acid, namely linolenic acid, is more than 40%, and is 140 times of that of olive oil. Has effects in reducing blood lipid, lowering blood pressure, enhancing immunity, preventing diabetes, preventing and treating cancer, and preventing apoplexy and myocardial infarction.
Green tea powder has good antioxidant and tranquilizing effects, and can relieve fatigue. The green tea contains vitamin C and flavonoid, wherein the flavonoid can enhance the antioxidant effect of vitamin C, and the green tea powder has effects of relieving constipation, reducing weight, and beautifying body.
Poria powder has effects of invigorating spleen and stomach, eliminating dampness, relieving swelling, calming heart and tranquilizing mind. Contains triterpenes, polysaccharides, choline, fat, lecithin, potassium, magnesium, etc. It can be used for treating diarrhea due to spleen deficiency, palpitation, insomnia, urination disorder, and edema. Can also improve the immunity of the organism, enhance the vitality of the human body and keep the health state of the human body. Meanwhile, the composition has the effects of strengthening spleen, nourishing heart, removing freckles, whitening skin, moistening skin, removing water and dampness, harmonizing stomach and calming heart, and has the effects of beautifying and nourishing skin and treating insomnia caused by stomach disharmony.
Coix seed, semen Coicis, has effects of inducing diuresis, eliminating dampness, invigorating spleen, relieving diarrhea, eliminating arthralgia, expelling pus, removing toxic substance, and resolving hard mass. Can be used for treating edema, loempe, dysuria, spleen deficiency, diarrhea, and damp arthralgia including cancer. Modern pharmacological research finds that the traditional Chinese medicine composition has the effects of regulating immunity, reducing blood sugar, resisting inflammation, relieving pain, resisting tumors and gastric ulcer and inducing ovulation.
The roxburgh rose powder is considered by traditional Chinese medicine, has the effects of promoting the production of body fluid, moistening dryness, clearing heat, reducing phlegm and relieving alcoholism, and is used for treating symptoms such as dry cough, thirst, constipation and the like caused by heat disease yin impairment or yin deficiency, and also can be used for symptoms such as polydipsia, cough and asthma, yellow phlegm and the like caused by internal heat. Modern researches find that the rosa roxburghii tratt has high nutritional value and is rich in substances such as vitamin C, polyphenol, organic acid, polysaccharide, flavone, trace elements and the like, wherein the content of the vitamin C is at the top of fruits, and the rosa roxburghii tratt triterpene and the flavone are the two main active ingredients. The pharmacological actions of fructus Rosae Normalis include resisting oxidation, resisting and preventing cancer, and reducing heavy metal load. Fructus Rosae Normalis has effects of regulating immunity, removing toxic substances, tranquilizing mind, delaying aging, resisting atherosclerosis and tumor, invigorating stomach, resolving food stagnation, preventing and treating diabetes, enhancing immunity, and resisting mutation.
Cordyceps militaris, also known as scarlet caterpiller fungus and scarlet caterpiller fungus, is a commonly used edible and medicinal fungus, and belongs to Ascomycotina (Ascomycotina), Clavicipitaceae (Clavicipitaceae) and Cordyceps (Cordyceps), and is the same fungus as Cordyceps sinensis. The main chemical components in the cordyceps militaris comprise cordycepin, cordyceps polysaccharide, cordycepic acid, protein, amino acid and the like, and the cordyceps polysaccharide has an immunoregulation effect; cordyceps polysaccharide, polyphenol and flavonoid have free radical scavenging effect. The cordycepin has inhibitory effect on growth of pathogenic bacteria such as Bacillus subtilis, Mycobacterium avium, Mycobacterium bovis, Streptococcus, Bacillus rhinoceros, Bacillus anthracis, Staphylococcus, and skin pathogenic fungi such as Trichophyton mentagrophytes and Trichophyton mentagrophytes; the polysaccharide and polypeptide components can provide neuroprotective effect; in addition, Cordyceps militaris also has effects of protecting liver, reducing blood lipid, reducing blood glucose, resisting virus, resisting tumor, and resisting radiation. The effects of protecting liver and reducing blood fat are mainly related to polysaccharide, polypeptide and some enzymes in the liver. Hypoglycemic effects may be associated with the removal of free radicals in the body, the improvement of the antioxidant capacity of the body and pancreas, and the repair of damaged B cells of the islets of langerhans.
Tuna peptide powder is a micromolecular active peptide substance obtained by taking tuna meat as a raw material and performing enzymolysis. The main functions of the device comprise: 1. and (3) fatigue resistance: on one hand, the activity of renal parasympathetic nerve is enhanced, on the other hand, the activity of lactic acid catabolic enzyme is enhanced to promote the conversion of lactic acid into energy and improve the motor ability; 2. reducing uric acid: HPRT (hypoxanthine phosphoribosyl transferase) is also known as a purine salvage enzyme, a purine reutilizing enzyme, a key enzyme in human purine metabolism. The purine metabolic process of the human body is as follows: purine in food is metabolized into intermediate products, then into final products, uric acid, which is discharged out of the body, and energy is released in the process. The function of HPRT enzymes is to resynthesize metabolic intermediates into purines for energy metabolism again. The increase of HPRT enzyme can improve the utilization rate of purine, reduce the generation of uric acid as metabolic waste and increase the energy produced by metabolism. In addition, bad living habits such as drinking can lead to accumulation of large amounts of lactic acid in the body leading to poor excretion of uric acid. Tuna peptides can cause the proliferation of HPRT and lactate dehydrogenase LDH, and the full metabolism of purine into energy, thereby reducing the uric acid as a metabolite.
The ginseng powder comprises the chemical components of ginsenoside, fat-soluble components, saccharides, amino acids, peptides and vitamins. The main functions comprise: 1. modulating the central nervous system; 2. the blood flow is accelerated, the metabolism in the body is promoted, the nutritional status of the organism is further adjusted, the physical decline is slowed down, and the resistance is enhanced; 3. has wide influence on endocrine system, under general condition, ginsenoside has excitation effect on pituitary adrenal cortex system, but under strong stress condition, adrenal cortex can be protected from functional failure. Ginsenoside can stimulate the secretion of gonadotropin and insulin; 4. ginsenoside has stimulating effect on lipid and sugar metabolism; 5. participate in immune regulation; 6. anti-tumor, anti-stress, anti-aging, etc.
As a preferred embodiment, the peony polypeptide powder further comprises the following raw material components: 0.5-5 parts of marine fish oligopeptide and 0.1-2 parts of corn oligopeptide. The marine fish oligopeptide and the corn oligopeptide can inhibit the rise of cholesterol and promote the secretion of insulin, thereby regulating the blood sugar of a human body and improving the disease of diabetes, and in addition, the marine fish oligopeptide and the corn oligopeptide can reduce blood fat and blood pressure and cholesterol, create an environment which is not favorable for the rise of uremia, accelerate the immunity of the body and protect bones from being influenced by uric acid.
As a preferred embodiment, the peony polypeptide powder further comprises the following raw material components: 0.1-2 parts of earthworm protein. The earthworm protein contains various components such as collagenase, plasmin, lumbrokinase, fibrinolytic activator protein, nucleic acid, trace elements and the like, has the molecular weight of 5000-10000, belongs to short-chain small molecular substances, can smoothly enter capillaries, dissolves micro-plugs in the capillaries and enables the hardened capillaries to recover elasticity, thereby relieving the blockage and distortion of the capillaries.
As a preferred embodiment, the peony polypeptide powder further comprises the following raw material components: 0.01-2 parts of sweetening agent.
As a preferred embodiment, the peony polypeptide powder comprises the following raw material components: 20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of green tea powder, 6 parts of poria cocos powder, 6 parts of semen coicis, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 0.5 part of marine fish oligopeptide, 0.5 part of corn oligopeptide, 1 part of ginseng powder, 0.2 part of earthworm protein and 0.01 part of sucralose.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
On the basis of the peony polypeptide powder, other auxiliary components can be added to prepare solid beverages in various forms according to the conventional preparation method in the field.
The peony polypeptide powder has multiple effects including acid discharge, dehumidification, sugar control, pressure stabilization, liver and kidney nourishing, and therefore the invention also relates to application of the peony polypeptide powder in preparation of functional food with the effects.
The invention has the beneficial effects that:
the peony polypeptide powder disclosed by the invention is prepared by combining a plurality of medicinal and edible Chinese herbal medicines including coconut milk powder, dandelion extract, corn stigma extract, peony seed oil microcapsule powder, green tea powder, poria cocos powder, coix seed, roxburgh rose powder, cordyceps militaris, tuna peptide powder and ginseng powder and assisting in proper weight proportion, wherein the tuna peptide powder and the corn stigma extract dilute uric acid, accelerate the metabolism of uric acid, prevent gout and dissolve tophus; the cordyceps militaris protects the liver, reduces blood fat and blood sugar, assists in reducing uric acid and accelerates excretion of uric acid; the ginseng powder improves microcirculation, supplements kidney qi and strengthens the metabolic capability of the kidney; the tuckahoe powder and the coix seed have the effects of tonifying spleen and promoting diuresis, and prevent the spleen function from being reduced due to moisture, so that uric acid is accumulated in the body; the Rosa roxburghii powder and the dandelion extract have the effects of strengthening heat clearing, detoxifying, promoting urination, removing dampness, assisting uric acid metabolism, improving liver function and promoting bile secretion; the peony seed oil microcapsule powder has the effects of reducing blood lipid, lowering blood pressure, enhancing autoimmunity, and preventing diabetes; the green tea powder and the coconut milk powder increase the intake of trace elements, protect the oxidation resistance of the organism and strengthen the metabolism of partial uric acid by the intestinal tract. The finally prepared peony polypeptide powder has the effects of promoting uric acid metabolism, eliminating dampness, removing food stagnation, assisting in reducing blood sugar, assisting in reducing blood pressure, nourishing and protecting liver, and tonifying spleen and kidney under the combined action of the components.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be described in detail below. It is to be understood that the described embodiments are merely a few embodiments of the invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the examples given herein without any inventive step, are within the scope of the present invention. In the following examples, 1 part by weight represents 1 g.
Example 1
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
15 parts of coconut milk powder, 25 parts of dandelion extract, 10 parts of maltodextrin, 25 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 15 parts of instant green tea powder, 5 parts of poria cocos powder, 15 parts of coix seed, 5 parts of roxburgh rose powder, 2 parts of cordyceps militaris, 0.1 part of tuna peptide powder and 2 parts of ginseng powder.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
Example 2
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
30 parts of coconut milk powder, 10 parts of dandelion extract, 25 parts of maltodextrin, 10 parts of corn stigma extract, 10 parts of peony seed oil microcapsule powder, 5 parts of instant green tea powder, 15 parts of poria cocos powder, 5 parts of coix seed, 15 parts of roxburgh rose powder, 0.1 part of cordyceps militaris, 2 parts of tuna peptide powder and 0.1 part of ginseng powder.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
Example 3
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of instant green tea powder, 6 parts of poria cocos powder, 6 parts of semen coicis, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 5 parts of marine fish oligopeptide, 0.1 part of corn oligopeptide and 1 part of ginseng powder.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
Example 4
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of instant green tea powder, 6 parts of poria cocos powder, 6 parts of semen coicis, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 3 parts of marine fish oligopeptide, 2 parts of corn oligopeptide and 1 part of ginseng powder.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
Example 5
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of instant green tea powder, 6 parts of poria cocos powder, 6 parts of coix seed, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 1 part of ginseng powder and 0.1 part of earthworm protein.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
Example 6
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of instant green tea powder, 6 parts of poria cocos powder, 6 parts of coix seed, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 1 part of ginseng powder and 2 parts of earthworm protein.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
Example 7
The embodiment provides peony polypeptide powder, which comprises the following raw material components in parts by weight:
20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of instant green tea powder, 6 parts of poria cocos powder, 6 parts of semen coicis, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 0.5 part of marine fish oligopeptide, 0.5 part of corn oligopeptide, 1 part of ginseng powder, 0.2 part of earthworm protein and 0.01 part of sucralose.
The preparation method of the peony polypeptide powder comprises the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (8)
1. The peony polypeptide powder is characterized by comprising the following raw material components in parts by weight:
15-30 parts of coconut milk powder, 10-25 parts of dandelion extract, 10-25 parts of maltodextrin, 10-25 parts of corn stigma extract, 5-10 parts of peony seed oil microcapsule powder, 5-15 parts of green tea powder, 5-15 parts of poria cocos powder, 5-15 parts of coix seed, 5-15 parts of roxburgh rose powder, 0.1-2 parts of cordyceps militaris, 0.1-2 parts of tuna peptide powder and 0.1-2 parts of ginseng powder.
2. The peony polypeptide powder according to claim 1, wherein the raw material components further comprise: 0.5-5 parts of marine fish oligopeptide and 0.1-2 parts of corn oligopeptide.
3. The peony polypeptide powder according to claim 1, wherein the raw material components further comprise: 0.1-2 parts of earthworm protein.
4. The peony polypeptide powder according to claim 1, wherein the raw material components further comprise: 0.01-2 parts of sweetening agent.
5. The peony polypeptide powder according to claim 1, wherein the raw material components comprise:
20 parts of coconut milk powder, 20 parts of dandelion extract, 13.79 parts of maltodextrin, 15 parts of corn stigma extract, 5 parts of peony seed oil microcapsule powder, 5 parts of green tea powder, 6 parts of poria cocos powder, 6 parts of semen coicis, 5 parts of roxburgh rose powder, 1 part of cordyceps militaris, 1 part of tuna peptide powder, 0.5 part of marine fish oligopeptide, 0.5 part of corn oligopeptide, 1 part of ginseng powder, 0.2 part of earthworm protein and 0.01 part of sucralose.
6. The preparation method of the peony polypeptide powder as claimed in any one of claims 1 to 5, which is characterized by comprising the following specific steps: respectively taking the raw materials, uniformly mixing the raw materials, and sterilizing to obtain the traditional Chinese medicine.
7. A solid beverage comprising the peony polypeptide powder according to any one of claims 1 to 5.
8. The use of the peony polypeptide powder as defined in any one of claims 1-5 for preparing functional food for removing acid and dampness, controlling and stabilizing blood sugar and blood pressure, and nourishing liver and kidney.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110973779.5A CN113679051A (en) | 2021-08-24 | 2021-08-24 | Peony polypeptide powder, solid beverage and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110973779.5A CN113679051A (en) | 2021-08-24 | 2021-08-24 | Peony polypeptide powder, solid beverage and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113679051A true CN113679051A (en) | 2021-11-23 |
Family
ID=78581812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110973779.5A Pending CN113679051A (en) | 2021-08-24 | 2021-08-24 | Peony polypeptide powder, solid beverage and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113679051A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115474637A (en) * | 2022-08-24 | 2022-12-16 | 上海中医药大学 | Solid beverage containing peony seed powder and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107136377A (en) * | 2017-06-21 | 2017-09-08 | 武汉万松堂健康产业有限公司 | A kind of compound solid beverage for being directed to gout and people with high uric acid and preparation method thereof |
CN110313619A (en) * | 2019-08-05 | 2019-10-11 | 世堃堂(广东)生物科技有限公司 | A kind of compound peptide and preparation method thereof with liver protecting |
CN110916200A (en) * | 2019-12-02 | 2020-03-27 | 广东微量元素生物科技有限公司 | Uric acid reducing composition and preparation method thereof |
CN111406867A (en) * | 2020-04-24 | 2020-07-14 | 洛阳牡仙实业有限公司 | Peony seed oil and cordyceps militaris solid beverage |
CN111436555A (en) * | 2020-04-24 | 2020-07-24 | 洛阳牡仙实业有限公司 | Peony seed oil and tea flower solid beverage |
CN111617231A (en) * | 2019-11-01 | 2020-09-04 | 北京同仁堂健康药业股份有限公司 | Uric acid-reducing and anti-gout composition as well as preparation method and application thereof |
-
2021
- 2021-08-24 CN CN202110973779.5A patent/CN113679051A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107136377A (en) * | 2017-06-21 | 2017-09-08 | 武汉万松堂健康产业有限公司 | A kind of compound solid beverage for being directed to gout and people with high uric acid and preparation method thereof |
CN110313619A (en) * | 2019-08-05 | 2019-10-11 | 世堃堂(广东)生物科技有限公司 | A kind of compound peptide and preparation method thereof with liver protecting |
CN111617231A (en) * | 2019-11-01 | 2020-09-04 | 北京同仁堂健康药业股份有限公司 | Uric acid-reducing and anti-gout composition as well as preparation method and application thereof |
CN110916200A (en) * | 2019-12-02 | 2020-03-27 | 广东微量元素生物科技有限公司 | Uric acid reducing composition and preparation method thereof |
CN111406867A (en) * | 2020-04-24 | 2020-07-14 | 洛阳牡仙实业有限公司 | Peony seed oil and cordyceps militaris solid beverage |
CN111436555A (en) * | 2020-04-24 | 2020-07-24 | 洛阳牡仙实业有限公司 | Peony seed oil and tea flower solid beverage |
Non-Patent Citations (1)
Title |
---|
牡丹荟俱乐部: "不用药物,营养也能治痛风?科学组方,降酸一身轻", 《HTTPS://MP.WEIXIN.QQ.COM/S/JH0PMHGCGVKPUIUADYVNOW》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115474637A (en) * | 2022-08-24 | 2022-12-16 | 上海中医药大学 | Solid beverage containing peony seed powder and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1170588A (en) | Pure natural plant human life energy nutritive substrate | |
CN101703221B (en) | Food supplement for incretion regulation, blood enrichment, skin maintenance, hairdressing and speckle removal and preparation method thereof | |
CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
CN102406115B (en) | Natural functional food for preventing cardiovascular and cerebrovascular diseases | |
KR20130056639A (en) | Health food fermented using effective micro-organisms with herbal medicine for reducing blood sugar and blood pressure and manufacturing method thereof | |
CN101724667A (en) | Technology for extracting dendrobium polysaccharide by applying biology engineering enzyme technology and product thereof and application | |
CN107136375A (en) | A kind of polygonatum Solomon's seal solid beverage | |
CN112972602A (en) | Preparation for treating blood sugar by fermenting Chinese herbal medicines for the aged and preparation method thereof | |
CN105639560A (en) | Biological-enzymolysis-method sporoderm-broken lucid ganoderma spore powder honey for calming nerves and aiding sleep and production process thereof | |
CN102763873B (en) | Rhizoma gastrodiae nutritional beverage and production process thereof | |
CN105533688A (en) | Healthcare soft capsule with assistant blood-sugar reducing effect and preparation method thereof | |
CN106244371A (en) | A kind of blood sugar lowering Rhizoma Polygonati grape health care wine and production technology thereof | |
CN107333926A (en) | A kind of Seabuckthorn healthcare tea and its preparation technology | |
CN113679051A (en) | Peony polypeptide powder, solid beverage and application thereof | |
CN107156820A (en) | Conditioning women postpartum is damaged nutraceutical of constitution and preparation method thereof comprehensively | |
CN106176909A (en) | A kind of method that Radix Ginseng Rhizoma Atractylodis Macrocephalae Poria Radix Glycyrrhizae prepares four gentleman's enzyme beverage | |
CN1943695A (en) | A tortoise preparation and its production technology | |
CN1060028C (en) | Health food macte from cereal, vegetable and fruit | |
CN106177166A (en) | A kind of compositions with function of physical fatigue alleviation and preparation method thereof | |
CN101248877A (en) | Anti-aging functional food and preparation method thereof | |
CN101642256B (en) | Method for preparing pox-removing face-beautifying milk | |
CN112402569A (en) | Anti-fatigue health product and preparation method thereof | |
CN104223051A (en) | Health plant nutrition powder | |
CN106579384A (en) | Comprehensive enzyme powder with lipolysis function and preparation method of comprehensive enzyme powder with lipolysis function | |
CN111418803A (en) | Preparation method of health preserving soup |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211123 |
|
RJ01 | Rejection of invention patent application after publication |